- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00581204
Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans
The purpose for this study is to measure the physiology of human undergoing a Lower Body Negative Pressure usea non-invasive low-power optical technique, near-infrared diffuse optical spectroscopy measurement and compare these measurement to standard monitoring procedures delineated in the Brooke Army Medical Center.
The Brooke Army Medical Center can use near-infrared diffuse optical spectroscopy to provide functional physiologic tissue and organ information without ionizing radiation and without withdrawing any blood, in a cost-effective and rapid manner. Monitoring for the onset of circulatory shock in a wounded soldier on the battlefield is typically performed by measurement of arterial blood pressure, arterial oxygen saturation, or simple auscultation of the pulse. Shock is typically recognized by non-specific signs and subjective symptoms such as cold clammy skin, pallor, weak thready pulse, unstable vital signs, and diminished mentation.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
California
-
Irvine, California, United States, 92612
- Beckman Laser Institute,University of California, Irvine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthy nonsmoking normotensive males or females.
- Age 18 to 55 years old, Military or civilian.
- Active duty military members who are 17 years old
Exclusion Criteria:
- Age <18 and >55 years, except for 17 year old active duty military members.
- History of hyperthyroidism,hypertension, cardiovascular abnormalitY, respiratory illnesses,anaphylaxis,pre-syncopal/syncopal episodes,abnormal blood clotting,
- Taking drugs to alter autonomic function
- History of alcohol or drug abuse
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Diagnostic Tool
Near-Infrared Diffuse Optical Spectroscopy Imaging
|
Early predictor of hemorrhagic shock
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Early predictor of shock
Time Frame: 5 to 60 seconds.
|
The near-infrared diffuse optical spectroscopy measure tissues properties
|
5 to 60 seconds.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Matthew Brenner, M.D, Beckman Laser Institute University of California Irvine
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20065191
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemorrhagic Shock
-
Massachusetts General HospitalBeth Israel Deaconess Medical Center; Boston Medical Center; Tufts Medical Center and other collaboratorsRecruiting
-
Jason SperryNational Heart, Lung, and Blood Institute (NHLBI)TerminatedHemorrhagic ShockUnited States
-
University of Texas Southwestern Medical CenterUniversity of Washington; Resuscitation Outcomes ConsortiumCompletedHemorrhagic ShockUnited States
-
Assiut UniversityUnknown
-
Assistance Publique - Hôpitaux de ParisTraumabase Group; Capgemini Invent; Ecole polytechnique; EHESS (Ecole des hautes... and other collaboratorsRecruitingWounds and Injuries | Hemorrhagic Shock | Traumatic ShockFrance
-
Assistance Publique - Hôpitaux de ParisRecruitingSepsis | Shock | Hemorrhagic ShockFrance
-
Haukeland University HospitalMinistry of Defence, NorwayCompletedHemorrhagic Shock | Hypovolemic ShockNorway
-
Isfahan University of Medical SciencesCompletedHemorrhagic Shock | IVC Collapsibility IndexIran, Islamic Republic of
-
Cristina MartinezCompleted
-
Haukeland University HospitalVestre Viken Hospital Trust; Oslo University Hospital; University Hospital of... and other collaboratorsCompletedUse of Blood and Plasma in Norwegian Physician-staffed Helicopter Emergency Medical System (ProHEMS)Hemorrhagic ShockNorway
Clinical Trials on Near-Infrared Diffuse Optical Spectroscopy
-
University of California, IrvineBeckman Laser Institute University of California IrvineWithdrawn
-
Drexel University College of MedicineCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedHypoxia-Ischemia, Brain | Signs and SymptomsUnited States
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedChronic Kidney DiseaseUnited States
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedAccessory; Breast TissueUnited States
-
Charite University, Berlin, GermanyMedtronic - MITGCompleted
-
Boston Children's HospitalNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSickle Cell DiseaseUnited States
-
Zekai Tahir Burak Women's Health Research and Education...UnknownAnemic Preterms, Cerebral Oxygenation,Somatic Oxygenation,Blood TransfusionTurkey
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedDiabetes MellitusUnited States